Transgenomic 2015 Sales Down on Loss of Revenues From Discontinued Operations | GenomeWeb

NEW YORK (GenomeWeb) – Transgenomic announced after the close of the market today a nearly 24 percent drop in sales for 2015, reflecting the loss of revenues from a number of business units the company has divested in order to focus on its ICE-COLD PCR molecular diagnostic offerings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.